Supply Chain Intelligence

Interpace Biosciences, Inc. Supply Chain

IDXG supply chain intelligence for Interpace Biosciences, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

IDXG ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

6Suppliers
10Customers
2Debt Items
20Related Chains

Interpace Biosciences, Inc. Suppliers

TickerNameConfidenceEvidence
ASURAGEN-INC ASURAGEN-INC 92% 10.20 Supply Agreement, dated August 13, 2014, by and between Interpace Diagnostics, LLC and Asuragen, Inc., incorporated by reference to Exhibit 10.33 of the Company’s Quarterly Report on Form 10-Q …
PRPH ProPhase Labs, Inc. 72% Reciprocal relationship from PRPH graph: COVID-19 and other RPP Molecular tests. Additionally, we compete against regional clinical laboratories providing diagnostic services, including Interpace Bio…
QGEN Qiagen N.V. 72% entific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche AG. While we have developed alternate sourcing strategies for most of these materials and vendors, we cannot be certain whether the…
QGEN Qiagen N.V. 72% Reciprocal relationship from QGEN graph: Reciprocal relationship from IDXG graph: entific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche AG. While we have developed alternate sourcing st…
TMO Thermo Fisher Scientific Inc. 72% tests from sole suppliers. We also purchase components used in our collection kits from sole-source suppliers. Some of these items are unique to these suppliers and vendors. Our most significant supp…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from IDXG graph: tests from sole suppliers. We also purchase components used in our collection kits from sole-source suppliers. Some of…

Interpace Biosciences, Inc. Customers

TickerNameConfidenceEvidence
LABORATORY-CORPORATION-OF-AMERICA LABORATORY-CORPORATION-OF-AMERICA 92% Our largest customer in 2025 for ThyGeNEXT ® and ThyraMIR ® v2 was Laboratory Corporation of America ® or LabCorp.
LABORATORY-CORPORATION-OF-AMERICA-OR-LABCORP LABORATORY-CORPORATION-OF-AMERICA-OR-LABCORP 92% Our largest customer in 2025 for ThyGeNEXT ® and ThyraMIR ® v2 was Laboratory Corporation of America ® or LabCorp. | Qwen verified: Explicit commercial relationship stated with LabCorp as largest cus…
LH Labcorp Holdings Inc. 92% Reciprocal relationship from LH graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from LH graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from LH graph: …
DGX Quest Diagnostics Incorporated 72% Reciprocal relationship from DGX graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from DGX graph: Reciprocal relationship from IDXG graph: ublications, and trade show exhibits.…
DGX Quest Diagnostics Incorporated 72% ublications, and trade show exhibits. We believe that our molecular diagnostic tests provide value to payers, physicians, and patients by improving patient care and lowering healthcare costs through …
PRPH ProPhase Labs, Inc. 72% Reciprocal relationship from PRPH graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from PRPH graph: COVID-19 and other RPP Molecular tests. Additionally, we compete against reg…
QGEN Qiagen N.V. 72% Reciprocal relationship from QGEN graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from QGEN g…
QGEN Qiagen N.V. 72% entific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche AG. While we have developed alternate sourcing strategies for most of these materials and vendors, we cannot be certain whether the…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from TMO graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from TMO grap…
TMO Thermo Fisher Scientific Inc. 72% tests from sole suppliers. We also purchase components used in our collection kits from sole-source suppliers. Some of these items are unique to these suppliers and vendors. Our most significant supp…

Interpace Biosciences, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
IDXG-DEBT-10189 Warrants outstanding: 875000 90% xbrl warrant detail from xbrl 2021-12-31.
IDXG-DEBT-10190 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-12-31.

Interpace Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Interpace Biosciences, Inc..

Interpace Biosciences, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Interpace Biosciences, Inc..

Interpace Biosciences, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CDNA CareDx, Inc. 100.00 2
IMTX Immatics N.V. 100.00 2
PRPH ProPhase Labs, Inc. 100.00 1 ['customer', 'supplier']
BHP BHP Group Limited 100.00 2
LH Labcorp Holdings Inc. 100.00 1 ['customer']
VRAX Virax Biolabs Group Limited 100.00 2
TWST Twist Bioscience Corporation 100.00 2
SOLV Solventum Corporation 100.00 2
PSNL Personalis, Inc. 100.00 2
BHPLF BHP Group Limited 100.00 2
CLLS Cellectis S.A. 100.00 2
IONS Ionis Pharmaceuticals, Inc. 100.00 2
MXCT MaxCyte, Inc. 100.00 2
ICLR ICON Public Limited Company 100.00 2
BTAI BioXcel Therapeutics, Inc. 100.00 2
AZTA Azenta, Inc. 100.00 2
STQN Strategic Acquisitions, Inc. 100.00 2
GH Guardant Health, Inc. 100.00 2
AETNA AETNA 63.48 1 ['receiving']
CIGNA CIGNA 63.48 1 ['receiving']
View IDXG supply chain intel →

Explore the full interactive supply chain map for Interpace Biosciences, Inc..

Open IDXG supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map